CVRx, Inc. (CVRX) Stock

CVRx, Inc. (CVRX) is a Healthcare stock trading at $4.95 (as of 2026-06-18), with a market capitalization of $148.07M and a trailing P/E of -2.5. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

CVRx, Inc. develops, manufactures, and commercializes neuromodulation devices for people with cardiovascular diseases, including its Barostim system for patients with heart failure with reduced ejection fraction or systolic heart failure. It sells in the United States, Germany, the rest of Europe, and internationally through a direct sales force, sales agents, and independent distributors.

Valuation — source: SEC EDGAR (first-party)
Price$4.95
Market Cap$148.07M
P/E Ratio-2.5
EV / EBITDA-2.4
Price / Book4.59
Price / Sales2.26
DCF Value (model)$-25.37
DCF Upside vs Price-612.5%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$56.65M
Net Margin-94.1%
Return on Equity-180.9%
Debt / Equity2.01
Current Ratio10.20
Revenue Growth (YoY)19.6%
EPS Growth (YoY)-5.7%
FCF Growth (YoY)-4.6%
Financial Health — source: SEC EDGAR
Altman Z-Score-6.76 (distress)
Piotroski F-Score3/9 (weak)
Valuation vs Sector & Industry
Stock P/E-2.5
Sector P/E (Healthcare)21.0
Industry P/E (Medical Equipment)31.7
vs Sector-111.9%
vs Industry-107.9%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderJOHNSON & JOHNSON ($38.08M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryMedical Equipment
CEOKevin Hykes
Employees206
CountryUS
IPO Date2021-06-30

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

  • Anteris Technologies Global Corp. (AVR)
  • Nyxoah S.A. (NYXH)
  • Nano-X Imaging Ltd. (NNOX)
  • 908 Devices Inc. (MASS)
  • Electromed, Inc. (ELMD)
  • Inogen, Inc. (INGN)
  • InfuSystem Holdings, Inc. (INFU)
  • OraSure Technologies, Inc. (OSUR)
CVRX earnings history · CVRX institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.